Med-tech manufacturer, Bedfont® Scientific Ltd., launches new CELLER8® PEMF device with exclusive distributor, NewMed Ltd. at the Health Optimisation Summit 2023.
FDA to pharma companies: Using CRO Synapse’s studies ‘unacceptable’
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS